{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Imaging Modalities for Lobular Carcinoma Detection"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised into two groups: traditional imaging (mammography and ultrasound) and advanced imaging (MRI, DBT, CEM, BSGI)"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were women aged 40-70 with suspected LC."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised into two groups: traditional imaging (mammography and ultrasound) and advanced imaging (MRI, DBT, CEM, BSGI)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates traditional and advanced imaging modalities for LC detection."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was diagnostic accuracy, measured over six months."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group allocation."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the traditional imaging group and 100 to the advanced imaging group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "In the intention-to-treat analysis, 98 participants in the traditional group and 97 in the advanced group were analysed."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Advanced imaging showed higher diagnostic accuracy (mean difference = 15%, 95% CI 10% to 20%; p < 0.001)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the advanced group and 1% in the traditional group experiencing mild discomfort."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01234567"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Cancer Institute."
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}